Various malignancies have been shown to express CD26, e.g., hepatocellular carcinoma, thyroid carcinoma, renal cell carcinoma, prostate cancer, gastrointestinal tumors, malignant mesothelioma, and some hematologic malignancies (22). This evidence concerns the gene DPP4 and renal cell carcinoma.